Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

  • Quoted phrase not found.
1.

Clinical Yield of Familial Screening After Sudden Death in Young Subjects: The French Experience.

Quenin P, Kyndt F, Mabo P, Mansourati J, Babuty D, Thollet A, Guyomarch B, Redon R, Barc J, Schott JJ, Sacher F, Probst V, Gourraud JB.

Circ Arrhythm Electrophysiol. 2017 Sep;10(9). pii: e005236. doi: 10.1161/CIRCEP.117.005236.

PMID:
28912206
2.

Transthyretin Cardiac Amyloidosis.

Mankad AK, Shah KB.

Curr Cardiol Rep. 2017 Aug 24;19(10):97. doi: 10.1007/s11886-017-0911-5. Review.

PMID:
28840452
3.

Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations.

Stevens CM, Rayani K, Singh G, Lotfalisalmasi B, Tieleman DP, Tibbits GF.

J Biol Chem. 2017 Jul 14;292(28):11915-11926. doi: 10.1074/jbc.M116.770776. Epub 2017 May 22.

PMID:
28533433
4.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.

Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH.

Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005311. doi: 10.1161/CIRCIMAGING.116.005311.

PMID:
28193612
5.

Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease.

Picano E, Ciampi Q, Citro R, D'Andrea A, Scali MC, Cortigiani L, Olivotto I, Mori F, Galderisi M, Costantino MF, Pratali L, Di Salvo G, Bossone E, Ferrara F, Gargani L, Rigo F, Gaibazzi N, Limongelli G, Pacileo G, Andreassi MG, Pinamonti B, Massa L, Torres MA, Miglioranza MH, Daros CB, de Castro E Silva Pretto JL, Beleslin B, Djordjevic-Dikic A, Varga A, Palinkas A, Agoston G, Gregori D, Trambaiolo P, Severino S, Arystan A, Paterni M, Carpeggiani C, Colonna P.

Cardiovasc Ultrasound. 2017 Jan 18;15(1):3. doi: 10.1186/s12947-016-0092-1.

6.

Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.

Ntusi NA, Shaboodien G, Badri M, Gumedze F, Mayosi BM.

Cardiovasc J Afr. 2016 May/Jun;27(3):152-158. doi: 10.5830/CVJA-2015-075.

7.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
8.

Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy: A case report with RAF1 770C>T mutant.

Wang X, Zhou K, Hua Y, Li Y.

Medicine (Baltimore). 2016 Sep;95(37):e4815. doi: 10.1097/MD.0000000000004815.

9.

Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.

Hiremath P, Lawler PR, Ho JE, Correia AW, Abbasi SA, Kwong RY, Jerosch-Herold M, Ho CY, Cheng S.

Circ Heart Fail. 2016 Sep;9(9). pii: e003026. doi: 10.1161/CIRCHEARTFAILURE.116.003026.

10.

Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy - Comparative Strain Imaging Study.

de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella G.

Circ J. 2016 Jul 25;80(8):1830-7. doi: 10.1253/circj.CJ-16-0364. Epub 2016 Jun 28.

11.

Disheartening Disparities.

Kidia KK.

N Engl J Med. 2016 Mar 10;374(10):909-11. doi: 10.1056/NEJMp1512888. No abstract available.

12.

Musculoskeletal manifestations of Fabry disease: A retrospective study.

Lidove O, Zeller V, Chicheportiche V, Meyssonnier V, Sené T, Godot S, Ziza JM.

Joint Bone Spine. 2016 Jul;83(4):421-6. doi: 10.1016/j.jbspin.2015.11.001. Epub 2015 Dec 14.

PMID:
26697993
13.

European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology.

Elliott P, Charron P, Blanes JR, Tavazzi L, Tendera M, Konté M, Laroche C, Maggioni AP; EORP Cardiomyopathy Registry Pilot Investigators.

Eur Heart J. 2016 Jan 7;37(2):164-73. doi: 10.1093/eurheartj/ehv497. Epub 2015 Sep 25.

PMID:
26409010
14.

Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.

Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL.

Genet Med. 2015 Nov;17(11):880-8. doi: 10.1038/gim.2014.205. Epub 2015 Jan 22. Erratum in: Genet Med. 2015 Apr;17(4):319.

PMID:
25611685
15.

A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification.

Hertz CL, Ferrero-Miliani L, Frank-Hansen R, Morling N, Bundgaard H.

Europace. 2015 Mar;17(3):350-7. doi: 10.1093/europace/euu210. Epub 2014 Oct 26. Review.

PMID:
25345827
16.

Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life.

Weber R, Kantor P, Chitayat D, Friedberg MK, Golding F, Mertens L, Nield LE, Ryan G, Seed M, Yoo SJ, Manlhiot C, Jaeggi E.

JACC Heart Fail. 2014 Aug;2(4):403-11. doi: 10.1016/j.jchf.2014.02.010. Epub 2014 Jul 9.

PMID:
25023818
17.

The Brockenbrough-Braunwald-Morrow sign.

Trevino AR, Buergler J.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):34-7.

18.

Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy.

Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, Lytle BW, Lever HM, Desai MY.

Am J Cardiol. 2014 Jun 1;113(11):1879-85. doi: 10.1016/j.amjcard.2014.03.020. Epub 2014 Mar 18.

PMID:
24837268
19.

Congenital heart disease in monochorionic twins with and without twin-to-twin transfusion syndrome.

Springer S, Mlczoch E, Krampl-Bettelheim E, Mailáth-Pokorny M, Ulm B, Worda C, Worda K.

Prenat Diagn. 2014 Oct;34(10):994-9. doi: 10.1002/pd.4411. Epub 2014 Jun 10.

PMID:
24827120
20.

Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Bratt EL, Östman-Smith I.

Cardiol Young. 2015 Mar;25(3):501-10. doi: 10.1017/S1047951114000237. Epub 2014 Mar 10.

Supplemental Content

Loading ...
Support Center